계정 가입
email 로 로그인
email 로 가입
수신함을 확인하세요
StageZero Life Sciences
About
StageZero Life Sciences is a biotech company developing and commercializing blood-based diagnostic tests for early disease detection.
- Richmond Hill,Ontario,Canada
- 1 - 10
Details
- Last Funding Type
- Post-IPO Equity
- Last Funding Money Raised
- $208K
- Industries
- Biotechnology,Health Care,Health Diagnostics
- Founded date
- Jan 1, 1998
- Number Of Employee
- 1 - 10
- Operating Status
- Active
- Stock Symbol
- otcqb:SZLSF
- Legal Name
- StageZero Life Sciences Ltd
- Also Known As
- GeneNews
StageZero Life Sciences is a biotech company developing and commercializing blood-based diagnostic tests for early disease detection. The company next-generation test, Aristotle, is a multi-cancer panel for simultaneously screening for 10 cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle is built on its proprietary mRNA technology platform, which was validated on 10,000 patients and used to develop the first liquid biopsy for Colorectal Cancer. StageZero Life Sciences was founded in 1998 and is based in Richmond Hill, Ontario, Canada.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 23, 2021 | Post-IPO Equity | $4.20M | — | — | — | Detail |
| Jul 12, 2021 | IPO | — | — | — | — | Detail |
| Feb 1, 2019 | Post-IPO Equity | $208K | 1 | — | — | Detail |
| Jul 31, 2017 | Post-IPO Equity | $245.55K | — | — | — | Detail |
| Apr 14, 2016 | Post-IPO Equity | $370.43K | — | — | — | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Keiretsu Forum
|
— | Post-IPO Equity |
Employee Profiles
Acquisition
StageZero Life Sciences has acquired 1 organizations. Their most recent acquisition was Health Clinics-clinics Operations on Aug 16, 2021. They acquired Health Clinics-clinics Operations for 0.
|
Date
Company Name
|
Industry | Acquisition Type | Price | |
|---|---|---|---|---|
|
Aug 16, 2021
|
Health Care | acquisition | — | Detail |
